Kezar Life Sciences to Present at Four Upcoming Virtual Medical and Scientific Conferences Oct 15, 2020 7:00am EDT
Kezar Highlights Data from MISSION Phase 1b Study of KZR-616 during the Pan American Congress of Rheumatology Sep 17, 2020 4:01pm EDT
Kezar Life Sciences to Present at The Myositis Association International Annual Patient Conference and the Pan-American Congress of Rheumatology Sep 10, 2020 7:00am EDT
Kezar Life Sciences Reports Second Quarter 2020 Financial Results and Provides Clinical and Business Update Aug 05, 2020 4:01pm EDT
Kezar Life Sciences to Participate in Two Upcoming Virtual Investor Conferences Aug 03, 2020 4:01pm EDT
Kezar Life Sciences to Release Second Quarter Financial Results and General Business Updates on August 5, 2020 Jul 29, 2020 5:17pm EDT
Kezar Announces Pricing of a Public Offering of $46.7 million of Common Stock and Pre-Funded Warrants Jun 08, 2020 8:48pm EDT
